Omni Partners’s Medicines Co MDCO Stock Holding History

Omni Partners’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,311,536	Closed	-$196K	–	78
2019 Q4	$196K	Buy	+2,311,536	New	+$154M	5.26%	4

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Omni Partners's MDCO Position: Q1 2020 in Review

Omni Partners sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 2,311,536 shares — an estimated $196K sold.

Omni Partners first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $196K in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Omni Partners reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Omni Partners sold 2,311,536 Medicines Co shares in Q1 2020, an estimated $196K.
Omni Partners first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
Omni Partners's Medicines Co position peaked at $196K in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Omni Partners's 13F filing for Q1 2020, filed 15 May 2020.